How Big Pharma is Using AI to Make Better Drugs
BERG will use its bAIcis® platform to help AstraZeneca identify biological targets in the battle against Parkinson’s Disease.
AI is Helping Turn Tide Against Flu in Two Important Ways
CEO Niven R. Narain discusses AI as a game-changer in battle against the flu.
Flu-pocalypse? Why Scientists are Scrambling to Make 'Universal Influenza Vaccine'
BERG CEO Niven Narain explains to Fox Business News how BERG will help business partner Sanofi to improve its flu vaccines.
BERG Teams with Mass General Hospital, Brigham and Women's Hospital to Combat Alzheimer's Disease
BERG CEO Niven Narain talks with WBZ Radio's Jeff Brown about how BERG, Mass General Hospital and Brigham and Women's Hospital will work together to battle Alzheimer's Disease.
BERG Helps Establish McLeod Research Fellowship at USUHS
The award will support an outstanding biomedical researcher to further accelerate the progress of ongoing prostate cancer research.
CEO Niven Narain Discusses Partnership with Sanofi Pasteur
CEO Niven Narain tells BBC 'World Business Report' about how partnership with Sanofi could bring about better flu vaccine.
Sanofi turns to artificial intelligence to beat flu
The French drugmaker Sanofi has teamed up with a US biotech group to use artificial intelligence in an effort to develop more effective flu vaccines.
BERG Supports PurpleStride 2017 in Fight Against Pancreatic Cancer
Employees, colleagues, family and friends of BERG will be participating in PurpleStride Boston 2017 to raise awareness and funds for pancreatic cancer research. Learn more.
CEO Niven Narain Sheds Light on New Prostate Cancer Diagnostic Test Developed for DoD
Narain discusses new prostate cancer diagnostic test developed for DoD, and how BERG uses AI to cut production time, cost of drug development.
CEO Niven Narain Discusses AI, AstraZeneca Partnership on BBC's "Talking Business"
In addition to discussing how artificial intelligence can improve the drug-development process, Narain talks about BERG's new collaboration with AstraZeneca.
AstraZeneca taps AI for drug discovery in deal with BERG
AstraZeneca has forged a research collaboration with Boston-based BERG, a specialist in artificial intelligence for drug hunting, in the latest sign of big pharma’s interest in using supercomputers for drug discovery.
The Next Frontier for A.I.? Drug Research
BERG CEO Niven Narain explains to the Cheddar Network how patient biological data, AI guides our drug-development efforts.
Pharma–Advocacy Partnerships: How the BERG–debra Partnership Helps EB Patients
CEO Niven Narain discusses the Berg-debra of America partnership, and how patient input is critical to understanding a rare disease.
Frontline Genomics talks to Ranga Sarangarajan about our AI guided GBM trials
BERG's Chief Scientific Officer, Ranga Sarangarajan talks to Liz Harley at Frontline Genomics about our Phase I/II glioblastoma multiforme trials that are being guided by BERG's AI platform.
BD Taps BERG’s AI Platform to Reduce Medication Non-Adherence
HIT Consultant has published an article on BERG Analytics multi-year commercial agreement with Becton Dickinson to apply our AI platform bAIcis™ to BD/MedMined hospital data.
The Economist: Will artificial intelligence help to crack biology?
In the Economist, our CEO Niven R. Narain explains how BERG uses artificial intelligence to analyze tissue samples and clinical data to model and understand diseases and guide drug discovery.
BERG Wages Hope for Pancreatic Cancer
Employees, colleagues, family and friends of BERG will be participating in Purplestride Boston 2016 to raise awareness and funds for pancreatic cancer research. Click for more.
Tech.co: BERG Aims to Lower Cost of Medicine with Artificial Intelligence
Tech.co talks to Niven Narain about how BERG is aiming to reduce the costs associated with developing treatments by utilizing patient biology and artificial intelligence.
Fortune: Feature on BERG Clinical trials
Fortune has published a feature article about BERG and the announcement of our Phase II trials in pancreatic cancer.
Mendelspod talks to Niven R Narain, CEO
The Mendelspod podcast talked to BERG's CEO Niven R. Narain to discuss how BERG is flipping drug development upside down by examining patient biology with the help of AI.
Bloomberg Radio - Taking Stock
Bloomberg Radio - Taking Stock talks to BERG's Co-Founder and CEO about precision medicine and our lead cancer therapeutic candidate BPM31510.
Bloomberg Advantage: Artificial Intelligence, Net Neutrality
The Bloomberg Advantage with Carol Massar and Cory Johnson sit down with Niven Narain Co-Founder and Chief Technology Officer of BERG
Huffington Post: Artificial Intelligence, What Will the Next 20 Years Bring?
Huffington Post offers its predictions for the future of Artificial Intelligence. BERG is cited as a leader in advancing the use of AI to make breakthrough drug discoveries.
HIT Consultant: Biotech Startup Hopes to Cure Cancer with Artificial Intelligence.
HIT Consultant covers BERG's approach to finding a cure for cancer.
IBT: Real Healthcare Revolution Is Happening With Artificial intelligence
International Business Times features BERG as part of the revolutionary changes coming to healthcare.
Niven Narain Presents at Wired UK 2015
BERG's President and CTO, Niven R. Narain presented at the Wired UK 2015 talks: "When Technology Gets Ambitions".
Boston Business Journal: NIH partners with Berg to investigate it lead drug in Kidney Cancer
NIH partners with Framingham biotech to develop cancer drug.
Genomeweb: Berg, U of Miami Extend Cardiovascular Disease Collaboration
BERG, U of Miami Extend Cardiovascular Disease Collaboration.
IBT: Experts suggest Artificial Intelligence could treat individuals based on genes, history
Experts suggest Artificial Intelligence could treat individuals based on genes, history.
Popular Science: How Artificial Intelligence Can Make Drugs Better and Faster
Popular Science covers AI and it's potential to for faster less expensive drug discovery.
Niven Narain talks to Diedre Bolton of Fox Business: Risk & Reward about Project Survival
Diedre Bolton of Fox Business: Risk & Reward talked to Niven Narain about our partnership with BIDMC, PCRT and CRAB
Re/Code: Artificial Intelligence Raises New Hope for Cancer Patients
RE/Code: Explores the use of AI to help find cures for cancer including BERG's approach.
The Journal of Precision Medicine: A New Hope for Pancreatic Cancer
BERG is featured in the inaugural issue of the Journal of Precision Medicine
Boston Globe - Research initiative targets pancreatic cancer
Research initiative targets pancreatic cancer
Fortune: An Audacious Attempt to Cure Pancreatic Cancer
Fortune features BERG's Pancreatic Cancer Partnership
NPR / WBUR - "Framingham Startup Uses Artificial Intelligence To Find Cancer Drugs"
WBUR and NPR's Curt Nickish discusses how BERG is using Artificial Intelligence and analytics to discover and develop cancer drugs.